PURE BIOSCIENCE, INC. (PURE)
About PURE BIOSCIENCE, INC.
PURE BIOSCIENCE
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $2.2M
- Net income
- -$2.4M
- Total assets
- $1.1M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Pure Bioscience, Inc. (PURE) Stock Price
- Reported a net loss of $2.4M in FY2025.
- Trading 10% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PURE BIOSCIENCE, INC..
Write a review
Pure Bioscience, Inc.: frequently asked questions
Is Pure Bioscience, Inc. an American company?
Pure Bioscience, Inc. is a US-based company headquartered in El Cajon, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Pure Bioscience, Inc. headquartered?
Pure Bioscience, Inc. is headquartered in El Cajon, California, United States.
Is Pure Bioscience, Inc. publicly traded?
Yes — Pure Bioscience, Inc. is a publicly traded company. Its stock trades under the ticker symbol PURE on the OTC.
What does Pure Bioscience, Inc. do?
Pure Bioscience, Inc. is an American Industrial Supplies company in the Manufacturing & Industrial sector.